Go Pro
OTCMKTS:POSC

Positron Q4 2025 Earnings Report

Positron logo
$1.87 +0.03 (+1.52%)
As of 09/28/2026 12:23 PM Eastern

Positron EPS Results

Actual EPS
-$0.22
Consensus EPS
N/A
Beat/Miss
N/A
One Year Ago EPS
N/A

Positron Revenue Results

Actual Revenue
$0.11 million
Expected Revenue
N/A
Beat/Miss
N/A
YoY Revenue Growth
N/A

Positron Announcement Details

Quarter
Q4 2025
Time
During Market Hours
Conference Call Date
N/A
Conference Call Time
N/A

Conference Call Resources

Positron Earnings Headlines

Positron Corp Stock Price History
The REAL Reason Trump is Invading Iran
For a moment… Forget about Trump’s ties to Israel. Forget about reports of Iran’s nuclear program. Because my research has led me to believe we’re risking World War 3 with Iran for a completely different reason.tc pixel
See More Positron Headlines
Get Earnings Announcements in your inbox

Want to stay updated on the latest earnings announcements and upcoming reports for companies like Positron? Sign up for Earnings360's daily newsletter to receive timely earnings updates on Positron and other key companies, straight to your email.

About Positron

Positron (OTCMKTS:POSC) Corporation is a medical technology company focused on positron emission tomography (PET), an imaging technique used to evaluate physiological activity in the body. The company’s business has centered on developing, manufacturing and commercializing PET imaging systems and related technologies for healthcare providers.

Positron has also been associated with radiopharmaceutical products and services that support PET procedures, as well as the installation, maintenance and servicing of imaging equipment. Its solutions are primarily intended for diagnostic applications, including cardiac and other clinical imaging uses.

Publicly available information about Positron Corporation’s current operations, geographic reach and leadership is limited. The company’s activities have historically been directed toward the medical-imaging market, but specific details regarding its present product portfolio and management team should be confirmed through its latest regulatory filings.

View Positron Profile